Lohist Dm Liquid
NDC Package 68047-129-16
Package Information
Lohist Dm (brompheniramine maleate, dextromethorphan hydrobromide and phenylephrine hydrochloride) liquids is do not exceed 6 doses in a 24-hour periodAgeDoseAdults and children over 12 years of age2 teaspoonsful (10 mL) every 4 hoursChildren 6 to under 12 years of age1 teaspoonful (5 mL) every 4 hoursChildren under 6 years of ageAsk your doctor. This formulation utilizes a liquid delivery system. Marketed by Larken Laboratories, Inc., this product is identified by NDC 68047-129 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1423702 - brompheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution
- RxCUI: 1423702 - brompheniramine maleate 0.4 MG/ML / dextromethorphan hydrobromide 2 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution
- RxCUI: 1423702 - brompheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 68047 - Larken Laboratories, Inc.
- 68047-129 - Lohist Dm
- 68047-129-16 - 473 mL in 1 BOTTLE
- 68047-129 - Lohist Dm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68047-129-16 identifies a specific commercial package of 473 ml in 1 bottle of Lohist Dm, a human over the counter drug labeled by Larken Laboratories, Inc.. This liquid is formulated for oral use and contains brompheniramine maleate; dextromethorphan hydrobromide; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Larken Laboratories, Inc. on June 01, 2012. The current certification is valid through December 31, 2026.
How is this Larken Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68047012916. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.